AB Science announces that results from masitinib study AB07015 in severe asthma have been selected for presentation at an ATS ...
Paris, 13 October 2020, 6pm Results from masitinib study AB07015 in severe asthma selected for presentation at an American Thoracic Society (ATS) symposium held on 16th October, 2020 AB Science SA (Euronext - FR0010557264 - AB) today announced that results …